Pharmaceuticals Industry: Giant Merger Creates Biotech Power

See allHide authors and affiliations

Science  15 Mar 1996:
Vol. 271, Issue 5255, pp. 1490
DOI: 10.1126/science.271.5255.1490


Berlin—The announcement last week that the Swiss drug giants Sandoz and Ciba-Geigy plan to merge is the latest in a series of consolidations that is changing the face of the world's pharmaceutical industry. The two companies last year spent a total of more than $2 billion on R&D. The new joint company, to be called Novartis, is expected to be a force in genome-related research, although some pruning of overlapping research is expected.